Genetic variants shared between Alzheimer's disease and Parkinson's disease have been discovered in blood and brain samples. Somatic mosaicism might function as an accelerator
Alzheimer's disease and Parkinson's disease are the most prevalent aging-related neurodegenerative disorders. Controversy continues over amyotrophic lateral sclerosis being classified as an aging-dependent neurodegenerative disease. Systems biology techniques are required to parse and integrate models to provide insights into the link between genetic features and phenotypes. The H2 MAPT haplotype, which codes for the microtubule-associated protein tau, has been related to LOAD risk. New research is now examining postzygotic variation in post-mortem variation in brain tissues of AD patients. The genome has been found to have 50% of the autosomal recessive parkinsonism patients with EO Parkinsonism and sensorimotor polyneuropathy. The gene for this gene, Park7, also known as DJ1, is the third gene involved with EOPD. It is the most frequent genetic risk factor for PD. This whole-genome sequencing had a 50-coding-exon deletion (from exon 17 to exon 66) in a patient with Eo Parkinsonism.